Enzyme found to control the formation of collagen carriers and inhibit collagen secretion has been identified by a research team at the Tokyo Institute of Technology. The findings could facilitate efficient production of collagen for the food, cosmetic, and pharmaceutical industries.
An enzyme called ‘USP8’ is the key enzyme involved in the controlling of collagen secretion, a research team at the Tokyo Institute of Technology (Tokyo Tech) claims. All of our cells make and release proteins. The proteins are packaged as "cargo" in tiny, bubble-like vesicles before being transported outside the cell. This process, known as secretion, is vital to healthy growth and development.
‘An enzyme called ‘USP8’ has been identified as the key enzyme that controls the formation of large collagen carriers. Controlling this enzyme may help us increase collagen secretion.’
Although many studies have shown how these vesicles, called COPII carriers, handle relatively small-sized cargo, few have focused on the workings of unusually large carriers known to package very large proteins, such as collagen.Now, a study by researchers including Masayuki Komada, Toshiaki Fukushima and graduate student Kohei Kawaguchi at Tokyo Institute of Technology has identified USP8 as a key enzyme involved in controlling the formation of large collagen carriers.
The team showed that "switching on" USP8 inhibited the formation of large carriers, and thus reduced collagen secretion. Conversely, switching USP8 off promoted collagen transport, which led to increased collagen secretion.
The findings have big implications for medicine and biotechnology. Excessive collagen secretion in the human body is known to cause organ fibrosis, while too little collagen secretion is associated with bone diseases including cranio-lenticulo-sutural dysplasia (CLSD) and Cole-Carpenter syndrome. New treatments for these diseases could be developed through further understanding of USP8's exact mode of action. Such knowledge could also provide new ways of scaling up commercial production of collagen.
The researchers have demonstrated that the enzyme works by deubiquitinating a protein called Sec31A, a component of the COPII vesicle coat required for protein export.
Advertisement
The study builds on many years of research that have illuminated the versatility of USP8.
Advertisement
It was this "accidental" finding, combined with promising results from other groups in the US that led the team to examine the role of USP8 in the formation of COPII carriers.
In research tracing back more than a decade, Komada and others have clarified the conventional role of USP8 in the regulation of endocytosis5. "It's very interesting that the same USP8-STAM1 complex has now been shown to play an important role both in the regulation of endocytosis and in secretion," Fukushima says.
The present study therefore reveals a "new face" of the USP8 enzyme, and Fukushima hints that there may be more surprises to come. USP8 belongs to a family of around 90 known deubiquitinating enzymes, which continue to be a hot topic in cellular biology.
The complete research report is published in the journal Biochemical and Biophysical Research Communications.
Source-Eurekalert